GGrantIndex
← Leaderboards

Edward C Hsiao

University Of California, San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$11,767,796
Attributed
$21,490,854
Total exposure
12
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2009–25
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,225,920 · 13

By mechanism

R01$8,247,094 · 5
UH3$6,887,844 · 1
UG3$2,346,696 · 1
T32$2,230,607 · 1
P30$1,017,851 · 2
K08$639,765 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsSignal TransductionOsteogenesisAffectInduced Pluripotent Stem CellHeterotopic OssificationMusculoskeletal DiseasesResponseBoneMutationRepairedFutureMacrophageImmunePathway InteractionsPreventInflammatoryInflammationFractureCytokineCell TypeReceptorAcvr1 GeneIn Vitro

Grant awards (43)

Diabetes, Endocrinology & Metabolism Training Grant$806,452
T32 · FY2025 · DK · contact PI
Core Center for Musculoskeletal Biology and Medicine$735,066
P30 · FY2025 · AR · contact PI
Novel Strategies for Understanding and Treating Fibrous Dysplasia$648,327
R01 · FY2025 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$640,847
R01 · FY2025 · AR
Administrative and Enrichment Core$282,785
P30 · FY2025 · AR · contact PI
An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva$191,862
R01 · FY2025 · AR · contact PI
Novel Strategies for Understanding and Treating Fibrous Dysplasia$35,542
R01 · FY2025 · AR · contact PI
Diabetes, Endocrinology & Metabolism Training Grant$691,349
T32 · FY2024 · DK · contact PI
Novel Strategies for Understanding and Treating Fibrous Dysplasia$646,333
R01 · FY2024 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$640,847
R01 · FY2024 · AR
An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva$177,650
R01 · FY2024 · AR · contact PI
Novel Strategies for Understanding and Treating Fibrous Dysplasia$29,618
R01 · FY2024 · AR · contact PI
Diabetes, Endocrinology & Metabolism Training Grant$732,806
T32 · FY2023 · DK · contact PI
Novel Strategies for Understanding and Treating Fibrous Dysplasia$699,594
R01 · FY2023 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$660,666
R01 · FY2023 · AR
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,287,847
UH3 · FY2022 · DK
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$669,078
R01 · FY2022 · AR
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,294,476
UH3 · FY2021 · DK
Pharmacologic modulation of innate immune dysfunction in heterotopic ossification$344,641
R01 · FY2021 · AR · contact PI
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$2,305,521
UH3 · FY2020 · DK
Pharmacologic modulation of innate immune dysfunction in heterotopic ossification$355,300
R01 · FY2020 · AR · contact PI
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$1,170,825
UG3 · FY2019 · DK
Innate immune regulation of stem cells in bone formation$348,700
R01 · FY2019 · AR · contact PI
Pharmacologic modulation of innate immune dysfunction in heterotopic ossification$347,776
R01 · FY2019 · AR · contact PI
Elucidating skeletal stem cell function using engineered 3D multicellular structures$276,305
R21 · FY2019 · AR · contact PI
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus$1,175,871
UG3 · FY2018 · DK
Pharmacologic modulation of innate immune dysfunction in heterotopic ossification$348,832
R01 · FY2018 · AR · contact PI
Innate immune regulation of stem cells in bone formation$348,700
R01 · FY2018 · AR · contact PI
Elucidating skeletal stem cell function using engineered 3D multicellular structures$210,925
R21 · FY2018 · AR · contact PI
Innate immune regulation of stem cells in bone formation$66,681
R01 · FY2018 · AR · contact PI
Elucidating skeletal stem cell function using engineered 3D multicellular structures$49,101
R21 · FY2018 · AR · contact PI
Innate immune regulation of stem cells in bone formation$348,700
R01 · FY2017 · AR · contact PI
Innate immune regulation of stem cells in bone formation$348,700
R01 · FY2016 · AR · contact PI
Innate immune regulation of stem cells in bone formation$348,700
R01 · FY2015 · AR · contact PI
A New Regulator of Trabecular Bone Formation$135,421
R03 · FY2013 · AR · contact PI
Regulation of Bone Formation by G-protein Signaling$127,953
K08 · FY2013 · AR · contact PI
Regulation of Bone Formation by G-protein Signaling$127,953
K08 · FY2012 · AR · contact PI
A New Regulator of Trabecular Bone Formation$77,250
R03 · FY2012 · AR · contact PI
A New Regulator of Trabecular Bone Formation$29,811
R03 · FY2012 · AR · contact PI
Regulation of Bone Formation by G-protein Signaling$127,953
K08 · FY2011 · AR · contact PI
A New Regulator of Trabecular Bone Formation$77,250
R03 · FY2011 · AR · contact PI
Regulation of Bone Formation by G-protein Signaling$127,953
K08 · FY2010 · AR · contact PI
Regulation of Bone Formation by G-protein Signaling$127,953
K08 · FY2009 · AR · contact PI